Search for: "Lilly v. State" Results 421 - 440 of 914
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Jun 2013, 5:02 am by Eric Alexander
  The only case the court had before it from a state court in one of the four states at issue was an unpublished decision in Linnen v. [read post]
26 Jun 2013, 6:43 am
  On the same day, no less, the IPKat learns of the consultation on the 15th draft of the Rules of Procedure of the UPC, and of Mr Justice Arnold’s exciting decision in Eli Lilly & Company v Janssen Alzheimer Immunotherapy (let’s call them Lilly and JAI). [read post]
25 Jun 2013, 6:13 pm by Lisa Milam-Perez
In Vance v Ball State University, the 5-4 majority endorsed a narrow definition of the meaning of “supervisor” for purposes of determining employer liability under Title VII. [read post]
21 Jun 2013, 10:22 am
[If you want some handy tips on how to speed-read all those comments, try the Wired How-To Wiki, here] In case you missed it, Eli Lilly and Company v Human Genome Sciences, Inc UKSC 2012/0220 is not going on appeal to the United Kingdom's Supreme Court. [read post]
12 Jun 2013, 1:53 pm
Patent No. 8,419,307) ·         Count V for Patent Infringement (Inducement to Infringe U.S. [read post]
6 Jun 2013, 11:48 am by S2KM Limited
"We’ve hit a home run for consumers,” announced Peter V. [read post]
30 May 2013, 10:34 am by S2KM Limited
Chiplin and Lilly begin their article with an extensive review of the historical debate concerning public health insurance in the United States. [read post]
28 Apr 2013, 8:40 am
Reciting Seager v Copydex and Banks v EMI Songs, the former judge stated that 'where an inventor wanted to sell his idea for money, money is what he got'. [read post]
1 Mar 2013, 11:56 am by Mary Jane Wilmoth
Eli Lilly and CompanyCase number: 12-cv-2045 (United States District Court for the District of Columbia)Case filed: December 20, 2012Qualifying judgment/order: January 2, 2013 02/08/2013 05/09/2013 2013-13 SEC v. [read post]
28 Feb 2013, 6:01 am
  Given Genentech's history of actively litigating this family of patents (see, e.g., MedImmune, Inc. v. [read post]